MPL Mutation Kit

Background on Myeloproliferative Neoplasms

Myeloproliferative Neoplasms (MPNs) are a group of hematologic disorders characterized by the abnormal proliferation of one or more myeloid cell lineages. These conditions, which include primary myelofibrosis, polycythemia vera, and essential thrombocythemia, are driven by mutations that affect hematopoietic regulation. Among these, mutations in the MPL gene—particularly W515K and W515L—play a central role in disease pathogenesis. Detection of these mutations is essential for research into disease mechanisms, biomarker development, and evaluation of targeted therapies.

Kit Description

The MPL™ Mutation Detection Kit provides a single-assay solution for the rapid and reliable identification of W515K and W515L mutations using real-time PCR technology. By detecting both mutations in a single reaction, the kit streamlines laboratory workflows, reduces handling steps, and ensures reproducible results. Optimized for research use, the kit is suitable for laboratories that require high sensitivity and specificity for MPN studies.

Integrated Positive Control

A built-in positive control is included to verify PCR system performance and support the interpretation of results. This dual function ensures assay reliability and reduces the risk of false-negative outcomes, supporting consistent and robust data across multiple experiments.

Reagents and Assay Performance

All reagents in the MPL™ Mutation Detection Kit are manufactured under strict quality standards. Primers, probes, and other PCR components are optimized for high specificity, allowing accurate detection even in samples with low mutant allele frequency. This is particularly important in MPN research, where variant allele burden can vary significantly.

The kit has been validated using reference materials and synthetic constructs, providing confidence in both reproducibility and performance. Its design allows integration with other molecular workflows, including DNA extraction methods, sequencing platforms, and complementary mutation analyses.

Biological and Research Significance

MPL W515K and W515L mutations activate the thrombopoietin receptor signaling pathway, leading to constitutive JAK-STAT activation. Understanding these mutations is critical for studying MPN pathophysiology, identifying prognostic markers, and developing therapeutic strategies. Reliable detection enables research into correlations between mutation status, disease phenotype, and treatment response, contributing to translational studies and potential clinical applications.

Summary

The MPL™ Mutation Detection Kit is a research-grade solution for accurate and reproducible detection of W515K and W515L mutations in MPNs. Its one-step assay format, integrated positive control, and validated reagents ensure high-quality results with minimal procedural complexity. Compatible with existing molecular workflows, the kit supports high-throughput research while maintaining analytical precision. By providing reliable detection of critical MPL mutations, the kit enables laboratories to advance understanding of MPN biology, support biomarker discovery, and contribute to the development of targeted therapies.